• 1
    Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA.1996;275:15711576.
  • 2
    Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardiol Clin.2010;28:571586.
  • 3
    Kanbay M, Turkmen K, Ecder T, Covic A. Ambulatory blood pressure monitoring: from old concepts to novel insights. Int Urol Nephrol.2012;44:173182.
  • 4
    Verdecchia P, Porcellati C, Schillaci G, et al.Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension.1994;24:793801.
  • 5
    de la Sierra A, Redon J, Banegas JR, et al.Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension.2009;53:466472.
  • 6
    Kahn HA, Medalie JH, Neufeld HN, et al.The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J.1972;84:171182.
  • 7
    Alper AB Jr, Chen W, Yau L, et al.Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension.2005;45:3438.
  • 8
    Dyer AR, Liu K, Walsh M, et al.Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens.1999;13:1321.
  • 9
    Grayson PC, Kim SY, Lavalley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res.2011;63:102110.
  • 10
    Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension.1991;17(6 Pt 2):969976.
  • 11
    Jossa F, Farinaro E, Panico S, et al.Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens.1994;8:677681.
  • 12
    Masuo K, Kawaguchi H, Mikami H, et al.Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension.2003;42:474480.
  • 13
    Nagahama K, Inoue T, Iseki K, et al.Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res.2004;27:835841.
  • 14
    Nakanishi N, Okamoto M, Yoshida H, et al.Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol.2003;18:523530.
  • 15
    Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens.2006;20:937945.
  • 16
    Sundstrom J, Sullivan L, D’Agostino RB, et al.Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension.2005;45:2833.
  • 17
    Taniguchi Y, Hayashi T, Tsumura K, et al.Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens.2001;19:12091215.
  • 18
    Cannon PJ, Stason WB, Demartini FE, et al.Hyperuricemia in primary and renal hypertension. N Engl J Med.1966;275:457464.
  • 19
    Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens.2007;25:15831589.
  • 20
    Bellomo G, Venanzi S, Saronio P, et al.Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension.2011;58:704708.
  • 21
    Redman CW, Beilin LJ, Bonnar J, Wilkinson RH. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet.1976;1:13701373.
  • 22
    Loeffler LF, Navas-Acien A, Brady TM, et al.Uric acid level and elevated blood pressure in US Adolescents: National Health and Nutrition Examination Survey, 1999–2006. Hypertension.2012;59:811817.
  • 23
    Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension.2003;42:247252.
  • 24
    Sanchez-Lozada LG, Soto V, Tapia E, et al.Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol.2008;295:F1134F1141.
  • 25
    Sanchez-Lozada LG, Tapia E, Lopez-Molina R, et al.Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol.2007;292:F1238F1244.
  • 26
    Mazzali M, Hughes J, Kim YG, et al.Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension.2001;38:11011106.
  • 27
    Mazzali M, Kanellis J, Han L, et al.Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol.2002;282:F991F997.
  • 28
    Watanabe S, Kang DH, Feng L, et al.Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension.2002;40:355360.
  • 29
    Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem.1991;266:86048608.
  • 30
    Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol.2005;16:35533562.
  • 31
    Kanbay M, Ozkara A, Selcoki Y, et al.Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol.2007;39:12271233.
  • 32
    Kanbay M, Huddam B, Azak A, et al.A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol.2011;6:18871894.
  • 33
    Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on the blood pressure of adolescents with newly diagnosed essential hypertension. JAMA.2008;300:922930.
  • 34
    Chobanian AV, Bakris GL, Black HR, et al.The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA.2003;289:25602572.
  • 35
    World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
  • 36
    Mazzali M, Kanbay M, Segal MS, et al.Uric acid and hypertension: cause or effect?Curr Rheumatol Rep.2010;12:108117.
  • 37
    Mohamed FA. The etiology of Bright’s disease and the prealbuminuric state. Med Chir Trans.1874;39:197228.
  • 38
    Schmidt MI, Watson RL, Duncan BB, et al.Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism.1996;45:699706.
  • 39
    Johnson RJ, Kang DH, Feig D, et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension.2003;41:11831190.
  • 40
    Verdecchia P, Schillaci G, Reboldi G, et al.Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension.2000;36:10721078.
  • 41
    Kario K, Pickering TG, Matsuo T, et al.Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension.2001;38:852857.
  • 42
    Mann S, Altman DG, Raftery EB, Bannister R. Circadian variation of blood pressure in autonomic failure. Circulation.1983;68:477483.
  • 43
    Sherwood A, Routledge FS, Wohlgemuth WK, et al.Blood pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J Hypertens.2011;24:982988.
  • 44
    Kaya MG, Yarlioglues M, Gunebakmaz O, et al.Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis.2010;209:278282.
  • 45
    Ermis N, Yagmur J, Acikgoz N, et al.Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clin Exp Hypertens.2012;34:311315.
  • 46
    Kanellis J, Watanabe S, Li JH, et al.Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension.2003;41:12871293.
  • 47
    Lyngdoh T, Marques-Vidal P, Paccaud F, et al.Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS ONE.2011;6:e19901.
  • 48
    Coutinho Tde A, Turner ST, Peyser PA, et al.Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens.2007;20:8389.
  • 49
    Wasilewska A. Is duration of breastfeeding in infancy associated with serum uric acid levels and markers of low-grade inflammation in children. Acta Paediatr.2012;March 27.
    Direct Link:
  • 50
    Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, et al.High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles. Atherosclerosis.2009;203:236242.
  • 51
    Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol.2008;28:11861192.